Spark Investment Management’s Protalix BioTherapeutics PLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-2,380
| Closed | -$10K | – | 874 |
|
|
2016
Q4 | $10K | Sell |
2,380
-3,730
| -61% | -$15.7K | ﹤0.01% | 763 |
|
|
2016
Q3 | $34K | Sell |
6,110
-1,210
| -17% | -$6.73K | ﹤0.01% | 800 |
|
|
2016
Q2 | $46K | Sell |
7,320
-3,643
| -33% | -$22.9K | ﹤0.01% | 755 |
|
|
2016
Q1 | $92K | Sell |
10,963
-11,997
| -52% | -$101K | 0.01% | 704 |
|
|
2015
Q4 | $234K | Buy |
22,960
+19,933
| +659% | +$203K | 0.03% | 553 |
|
|
2015
Q3 | $35K | Buy |
3,027
+1,407
| +87% | +$16.3K | ﹤0.01% | 656 |
|
|
2015
Q2 | $31K | Hold |
1,620
| – | – | ﹤0.01% | 642 |
|
|
2015
Q1 | $28K | Sell |
1,620
-6,420
| -80% | -$111K | ﹤0.01% | 693 |
|
|
2014
Q4 | $147K | Sell |
8,040
-1,350
| -14% | -$24.7K | 0.02% | 540 |
|
|
2014
Q3 | $227K | Buy |
9,390
+4,750
| +102% | +$115K | 0.03% | 494 |
|
|
2014
Q2 | $169K | Buy |
+4,640
| New | +$169K | 0.03% | 511 |
|